Nasway Use as an Independent Adverse Prognostic Factor in Oral Squamous Cell Carcinoma: A Retrospective Cohort Study from Uzbekistan. JOC. 2026;25(1):671-679. doi:10.66838/J.Carcinog.25.1.671-679